Prothena News

Cantor Fitzgerald Corp.: Prothena Corp (PRTA.US) shareholding rating confirmed.

Zhitong FinanceApr 11 01:31

Prothena Corp Analyst Ratings

BenzingaApr 11 01:25

Prothena Corp Analyst Ratings

BenzingaMar 13 21:24

Analysts Offer Insights on Healthcare Companies: Crinetics Pharmaceuticals (CRNX), Belite Bio, Inc. ADR (BLTE) and Prothena (PRTA)

TipRanksMar 13 18:20

Piper Sandler Reaffirms Their Buy Rating on Prothena (PRTA)

TipRanksMar 7 20:36

Oppenheimer Cuts Prothena Price Target to $80 From $98, Maintains Outperform Rating

MT NewswiresFeb 20 21:42

Buy Rating Affirmed on Prothena Amid Strong Pipeline Progress and Solid Financials

TipRanksFeb 19 12:45

JMP Securities Maintains Market Outperform on Prothena Corp, Raises Price Target to $85

BenzingaFeb 17 03:58

Prothena Corp Analyst Ratings

BenzingaFeb 17 01:41

RBC Trims Price Target on Prothena to $35 From $36, Keeps Sector Perform, Speculative Risk

MT NewswiresFeb 16 21:16

RBC Capital Reaffirms Their Hold Rating on Prothena (PRTA)

TipRanksFeb 16 20:40

Promising Outlook for Prothena's Amyloidosis Treatments: Analyst Endorses Buy Rating

TipRanksFeb 16 19:25

Prothena Corp Analyst Ratings

BenzingaJan 30 21:04

Prothena Corp Analyst Ratings

BenzingaJan 26 00:50

RBC Cuts Price Target on Prothena to $36 From $43, Calls Initial Data on PRX012 'Anticlimactic,' Keeps Sector Perform, Speculative Risk

MT NewswiresJan 25 21:03

RBC Capital Remains a Hold on Prothena (PRTA)

TipRanksJan 25 20:28

Buy Rating on Prothena's Stock Amid Early Positive Signals for Alzheimer's Drug PRX012

TipRanksJan 11 14:38

Prothena (PRTA) Gets a Buy From Piper Sandler

TipRanksJan 10 20:18

Cantor Fitzgerald Maintains Overweight on Prothena Corp, Lowers Price Target to $87

BenzingaJan 9 22:08

Prothena Corp Analyst Ratings

BenzingaJan 9 22:07